Cost Plus Drugs could be selling drugs to hospitals by this fall

Mark Cuban Cost Plus Drug Co. plans to be selling drugs to hospitals and clinics by September or October, the company's CEO and co-founder Alex Oshmyansky, MD, PhD, told Dallas-based D Magazine

The pharmaceutical company launched its mail-order pharmacy services in January 2022 with about 100 drugs. It now sells more than 1,000 generics and 10 brand-name medications, has a network of independent pharmacies spanning 38 states, and partners with pharmacy benefit managers and Capital Blue Cross. 

Cost Plus Drugs' 22,000-square-foot, $11 million finish-and-fill drug manufacturing facility in Dallas received its pharmaceutical manufacturing license from the Texas Board of Pharmacy on July 17, according to the magazine. The next steps for the plant include figuring out logistics and procurement details with hospitals and FDA inspections. 

The company has not released a list of the drugs it plans to manufacture, but Mark Cuban and Dr. Oshmyansky have said the portfolio will focus on critical drugs in shortage — of which there are about 300.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars

/30116360/HR_Homepage_300x250-1

/30116360/HR_Homepage_300x250-2